VIR:NASDAQ, Vir Biotechnology, Inc.

Why VIR stock rose on November 6

Vir Biotechnology, Inc. rose 10.8% on Friday, November 6, 2026, on 1,886,950 shares. Headlines around the move:

Nov 5: Vir Bio (VIR) Q3 2026 Earnings Call Transcript
Nov 5: Vir Biotechnology to Present Topline Phase 3 ECLIPSE 1 Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta at AASLD's The Liver Meeting® 2026 and Host Investor Conference Call
Nov 5: Vir Biotechnology to Present Topline Phase 3 ECLIPSE 1 Data for Elebsiran and Tobevibart in Chronic Hepatitis Delta at AASLDs The Liver Meeting 2026 and Host Investor Conference Call

VIR stock overview

Vir Biotechnology, Inc. (VIR:NASDAQ) closed at $12.21 on November 6, 2026, up 10.80% on the day. The stock trades 1.9% below its 52-week high of $12.45 and 153.6% above its 52-week low of $4.82. Over the past year, it gained 138.0%. Vir Biotechnology, Inc. is part of the Health Care sector.

Key figures

Price: $12.21
Day change: +10.80%
Volume: 1,886,950
Average volume: 1,949,168
Market cap: 2B+
52-week range: $4.82 – $12.45
50-day average: $11.01
200-day average: $9.62

Price action over the past year

In 252 trading sessions since November 6, 2025, VIR closed higher on 128 days (51%). Its best day was February 24, 2026 (+27.73%) and its worst was May 7, 2026 (-9.91%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 1 time.

Recent signals

Nov 7, 2026: News catalyst: Biotech (News Catalysts scanner)
Nov 6, 2026: Hit a new 52-Week High of $12.21 (New Highs/Lows scanner)
Nov 6, 2026: Trading sideways between $11.00 and $12.21 over 14 days (Sideways scanner)

VIR news

About Vir Biotechnology, Inc.

Vir Biotechnology Inc is a clinical-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions.

Similar stocks

Find more stocks like VIR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.